Sample Available Antibacterial Ethylene Oxide Disinfecting Type High Control Precision China Flow Regulator Suppliers

Name: Sample Available Antibacterial Ethylene Oxide Disinfecting Type High Control Precision China Flow Regulator Suppliers
Brand: Changzhou Sunton Medical Technology Co., Ltd.
SKU: 1966198222

Jiangsu, ChinaChangzhou Sunton Medical Technology Co., Ltd.

US$6.90

10,000-99,999 Pieces

US$5.90

100,000-999,999 Pieces

US$4.69

1,000,000+ Pieces

Sample price:US$8.00/piece.Request sample

Product profile

Customization

Available

Type

Face Mask/Apron/Gloves

Material

Plastic

Model NO.

IV Flow Regulator

Ethylene Oxide Sterilization

Without Ethylene Oxide Sterilization

Quality Guarantee Period

Two Years

Group

Adult

Logo Printing

With Logo Printing

Product Name

IV Flow Regulator

Regulator Material

White ABS and Clear TPE

Colour

Green or Blue

Max Operating Pressure

0.5 Bar in Static Condition, Gravity Set

Max Sterilization Temperature

50 Degrees Celsius

Operating Range

10 to 250 Ml/H,5 to 200 Ml/H

Latex-Free

Yes

Dehp-Free

Yes

Length

92 Inch

Speed

20 Drops/Ml

Injection Site

Y-Injection Site

Features 1

Rotating Male Luer Lock Connector

Features 2

Universal Vented/Non-Vented Spike

Features 3

Roller Clamp

Features 4

15 Micron Filter Located in Drip Chamber

Transport Package

Blister/PE Bag/Customization

Specification

On-Demand Customization

Trademark

Sunton

Origin

China

HS Code

9018390000

Company profile

Changzhou Sunton Medical Technology Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/FactoryAverage Response Time: ≤4.22h

AI-Powered supplier vetting

SummaryThe supplier presents capabilities in medical products, including airway management, feeding and drainage tubes, IV therapy, vascular access, wound care, urology, nonwoven, and surgical products. It states that its facilities hold ISO13485 certification and its products have CE0197 certification. The supplier offers extensive customization and ODM services and reports OEM service for popular brands. However, quality control appears limited, with one quality inspector, random finished-product inspection, and checks performed by packing staff. Service management lacks written procedures or records for supplier evaluation, corrective actions, and complaint handling. The supplier has no overseas showroom, agents, branches, overseas warehouse, or inventory capability, though it has participated in MEDICA 2024. Innovation evidence is limited because no new products were reported in the past year. Production-capacity controls are unclear, and the supplied financial records contain zero values, preventing a...

Supplier typeThe company describes a broad medical-device product portfolio covering airway management, feeding and drainage, IV therapy and vascular access, wound care, urology, nonwoven, and surgical products. This supports classification as a medical products supplier, although the slices do not identify a more specific legal or manufacturing type.

CertificationsThe supplier states that its facilities have obtained ISO13485 certification and that its products have received CE0197 certification. These are explicit certification claims in the company description, supporting a positive assessment.

After-Sales capabilityAfter-sales and service infrastructure appears limited: there are no written procedures or records for service assessment, corrective and preventive actions, or complaint handling. The supplier has no overseas showroom, agents or branches, overseas warehouse, or inventory capability, although it accepts multiple quotation and payment terms and has participated in one offline trade show.

Financial creditThe supplied financial records report zero operating revenue, costs, profits, margins, and current-ratio values for the stated periods. Because these figures do not demonstrate financial strength or provide a positive credibility signal, the supplier cannot be favorably assessed on this field.

R&D capabilityThe supplier offers ODM services and broad design customization, but it reports no new products in the past year and no available SDK. The explicit lack of recent new-product information is a deficiency for innovation assessment, despite the design-service capability.

Customization capabilityThe supplier explicitly provides customization from samples, customization from designs, full customization, minor customization, flexible customization, and ODM services. The consistency of these capabilities across quality/design and R&D-related records supports a positive assessment.